
AI Coverage
about 23 hours ago
FDA Clears AI-Enabled Ultrasound for High-Volume Clinical Settings9 days ago
Top Five Radiology Content in June 2026Latest News

FDA Clears AI-Enabled Ultrasound for High-Volume Clinical Settings

Canon Medical Unveils Advances in AI-Enabled CT Software

Study Says Use of 18F-flotufolastat PET/MRI May Reduce Prostate Biopsies by More Than 50 Percent

Can the New PACS Viewer Bolster Efficiency in Radiology Workflows?

AI in Radiology: Emerging Trends, Current Obstacles and Future Directions

Shorts










Podcasts
Videos
All News

In comparison to everolimus, the peptide receptor radionuclide therapy (177Lu)Lu-edotreotide provided over a nine month longer median progression-free survival for patients with gastroenteropancreatic neuroendocrine tumours (GEP NETs), according to new phase 3 research.

In an amusing take on the subject, this author suggests that having a colleague with dedicated expertise in curtailing unnecessary imaging requests could have an impact in reducing burgeoning worklists.

Catch up on the top radiology content of the past week.

For patients with known or suspected neuroendocrine tumors, the radiopharmaceutical 64Cu-SARTATE offered over 50 percent higher average detection of liver foci than 68Ga-DOTATATE at four hours and 20 hours post-injection, according to research presented at the recent SNMMI conference.

In a recent interview, Amy Patel, MD, discussed recent research on breast cancer screening, pertinent obstacles and keys to facilitating improved adherence with mammography screening.

While acknowledging key limitations, the authors of a new literature review noted that contrast-enhanced mammography offers a viable alternative to conventional imaging and breast MRI for preoperative tumor evaluation and may have a significant impact on surgical management.

Emerging research demonstrates that those with total plaque volume > 750 mm3 have an 18.6 percent risk of MACE at four years in comparison to a 1.4 percent MACE risk for those with no plaque.

The Star RF Electrode and VIVA RF Electrode are reportedly the first devices to garner a specific cleared indication for benign thyroid nodule ablation.

In comparison to the 2009 International Federation of Gynecology and Obstetrics (FIGO) staging system for endometrial cancer, researchers found that the updated 2023 FIGO system had over a 17 percent decrease for substage agreement between pelvic MRI and pathology findings.

The Mammomat B.brilliant’s ClearCEM image reconstruction technique reportedly utilizes advanced algorithms to facilitate improved noise reduction and lesion enhancement.

In recent interviews with Diagnostic Imaging, Jeremie Calais, MD, PhD, Michael Hofman, MBBS, FRACP, Heather Jacene, MD, Phillip Kuo, MD, and more shared their thoughts about the potential impact of theranostics and what excites them about the future of nuclear medicine.

Catch up on the most well-viewed video interviews from Diagnostic Imaging in June 2026.

In order to fully take advantage of the capabilities of AI, this author emphasizes key principles and a framework for converting isolated technology solutions into reliable components of radiology workflows and operations.

The words you say, how you say them and the tone in which you say them may impact perceptions of your credibility.
























